Phase 2 PTSD Trial, Recruiting (NCT06073886)

Phase 2 PTSD Trial, Recruiting NCT06073886 Sponsor: University of California, Los Angeles Condition: PTSD

Printed from Voxsanity (voxsanity.com.au) — NCT06073886 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Ptsd

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have had a mild traumatic brain injury (concussion) within the last 12 months, diagnosed using World Health Organization guidelines
You were between 18 and 65 years old at the time of your concussion
You are currently experiencing a high level of post-concussion symptoms, shown by scoring 20 or higher on a standard post-concussion symptom questionnaire (confirm with trial site)

Who may not be able to join:

You have measurable neurological problems that a doctor can detect during an examination (confirm with trial site)
You had a previous concussion within the past 2 years that caused symptoms lasting longer than 3 months
You have previously received a treatment called transcranial magnetic stimulation (TMS), which uses magnetic pulses directed at the brain
You have a reason why TMS treatment or MRI scans would not be safe for you, such as having a metal implant in your body (not including dental work) or a pacemaker
You have a serious mental, physical, or medical condition that could make participation difficult or unsafe, such as liver, kidney, or heart disease, uncontrolled diabetes or high blood pressure, cancer, psychosis, a history of seizures, or pregnancy
You are currently misusing alcohol or illegal drugs
You are unable to speak and read English

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 20 July 2026

Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: (818)392-4614

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06073886

Sponsor: University of California, Los Angeles

Phase: Phase 2

Status: Recruiting

Condition: PTSD

Trial contact: (818)392-4614

More information: https://clinicaltrials.gov/study/NCT06073886

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have had a mild traumatic brain injury (concussion) within the last 12 months, diagnosed using World Health Organization guidelines
You were between 18 and 65 years old at the time of your concussion
You are currently experiencing a high level of post-concussion symptoms, shown by scoring 20 or higher on a standard post-concussion symptom questionnaire (confirm with trial site)

Who may not be able to join:

You have measurable neurological problems that a doctor can detect during an examination (confirm with trial site)
You had a previous concussion within the past 2 years that caused symptoms lasting longer than 3 months
You have previously received a treatment called transcranial magnetic stimulation (TMS), which uses magnetic pulses directed at the brain
You have a reason why TMS treatment or MRI scans would not be safe for you, such as having a metal implant in your body (not including dental work) or a pacemaker
You have a serious mental, physical, or medical condition that could make participation difficult or unsafe, such as liver, kidney, or heart disease, uncontrolled diabetes or high blood pressure, cancer, psychosis, a history of seizures, or pregnancy
You are currently misusing alcohol or illegal drugs
You are unable to speak and read English

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 20 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 2

Sponsor

University of California, Los Angeles

Registry

ClinicalTrials.gov

Start date

6 March 2024

Est. completion

1 July 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Central target engagement, modulation, and durability; Peripheral target engagement, modulation, and durability; Persistent post-concussive symptoms modulation and durability; Fear avoidance modulation and durability

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov